To count and how to count, that is the question: Interobserver and intraobserver variability among pathologists in lymph node counting

American Journal of Clinical Pathology

Volumn 134, Issue 1, 2010, Pages 42-49

  Parkash, Vinita ^a   Bifulco, Carlo ^a   Feinn, Richard ^a,b   Concato, John ^a,b   Jain, Dhanpat ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

Author keywords

Cancer staging; Interobserver variability; Intraobserver variability; Lymph node counting

Indexed keywords

ARTICLE; CANCER STAGING; HUMAN; INTEROBSERVER VARIABILITY; INTRAOBSERVER VARIABILITY; LOCAL LYMPH NODE ASSAY; LYMPH NODE; LYMPHADENECTOMY; MEASUREMENT; OBSERVER VARIATION; PATHOLOGIST; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; QUESTIONNAIRE; STATISTICAL ANALYSIS;

HUMANS; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; NEOPLASM STAGING; NEOPLASMS; OBSERVER VARIATION; QUESTIONNAIRES; SPECIMEN HANDLING; TISSUE FIXATION;

EID: 77954498399     PISSN: 00029173     EISSN: 19437722     Source Type: Journal    
DOI: 10.1309/AJCPO92DZMUCGEUF     Document Type: Article

References (32)

1. Smith DD, Schwarz RR, Schwarz RE. Impact of total lymph node count on staging and survival after gastrectomy for gastric cancer: data from a large US-population database. J Clin Oncol. 2005;23:7114-7124. (Pubitemid 46260299)
2. Johnson PM, Porter GA, Ricciardi R, et al. Increasing negative lymph node count is independently associated with improved long-term survival in stage IIIB and IIIC colon cancer. J Clin Oncol. 2006;24:3570-3575.
3. Cozzaglio L, Doci R, Celotti S, et al. Gastric cancer: extent of lymph node dissection and requirements for a correct staging. Tumori. 2004;90:467-472. (Pubitemid 39556795)
4. Lutman CV, Havrilesky LJ, Cragun JM, et al. Pelvic lymph node count is an important prognostic variable for FIGO stage I and II endometrial carcinoma with high-risk histology. Gynecol Oncol. 2006;102:92-97.
5. Brennan RL. Generalizability Theory. New York, NY: Springer-Verlag; 2001.
6. Goldstein NS. Lymph node recoveries from 2427 pT3 colorectal resection specimens spanning 45 years: recommendations for a minimum number of recovered lymph nodes based on predictive probabilities. Am J Surg Pathol. 2002;26:179-189.
7. National Quality Forum endorsed Commission on Cancer measures for quality of cancer care for breast and colorectal cancers [press release]. Chicago, IL: American College of Surgeons; April 12, 2007.
8. Wong SL, Ji H, Hollenbeck BK, et al. Hospital lymph node examination rates and survival after resection for colon cancer. JAMA. 2007;298:2149-2154.
9. Rieger NA, Barnett FS, Moore JW, et al. Quality of pathology reporting impacts on lymph node yield in colon cancer [letter]. J Clin Oncol. 2007;25:463.
10. Baxter NN. In reply [letter]. J Clin Oncol. 2007;25:463-464.
11. Galvis CO, Raab SS, D'Amico F, et al. Pathologists' assistants practice: a measurement of performance. Am J Clin Pathol. 2001;116:816-822.
12. Ostadi MA, Harnish JL, Stegienko S, et al. Factors affecting the number of lymph nodes retrieved in colorectal cancer specimens. Surg Endosc. 2007;21:2142-2146.
13. Candela FC, Urmacher C, Brennan MF. Comparison of the conventional method of lymph node staging with a comprehensive fat-clearing method for gastric adenocarcinoma. Cancer. 1990;66:1828-1832. (Pubitemid 20381223)
14. Brown HG, Luckasevic TM, Medich DS, et al. Efficacy of manual dissection of lymph nodes in colon cancer resections. Mod Pathol. 2004;17:402-406.
15. Kim YM, Suh JH, Cha HJ, et al. Additional lymph node examination from entire submission of residual mesenteric tissue in colorectal cancer specimens may not add clinical and pathologic relevance. Hum Pathol. 2007;38:762-767.
16. Compton CC. Key issues in reporting common cancer specimens: problems in pathologic staging of colon cancer. Arch Pathol Lab Med. 2006;130:318-324.
17. Compton CC, Fielding LP, Burgart LJ, et al. Prognostic factors in colorectal cancer: College of American Pathologists Consensus Statement 1999. Arch Pathol Lab Med. 2000;124:979-994.
18. Lawrence WD. ADASP recommendations for processing and reporting of lymph node specimens submitted for evaluation of metastatic disease. Virchows Arch. 2001;439:601-603. (Pubitemid 33071195)
19. Van der Valk P, Meijer CJLM. Lymph nodes. In: Mills S, ed. Histology for Pathologists. 3rd ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2007:763-781.
20. Genereux GP, Howie JL. Normal mediastinal lymph node size and number: CT and anatomic study. AJR Am J Roentgenol. 1984;142:1095-1100.
21. Thorn CC, Woodcock NP, Scott N, et al. What factors affect lymph node yield in surgery for rectal cancer? Colorectal Dis. 2004;6:356-361.
22. Dottino PR, Tobias DH, Beddoe A, et al. Laparoscopic lymphadenectomy for gynecologic malignancies. Gynecol Oncol. 1999;73:383-388.
23. Nijman HW, Khalifa M, Covens A. What is the number of lymph nodes required for an "adequate" pelvic lymphadenectomy? Eur J Gynaecol Oncol. 2004;25:87-89.
24. Possover M, Krause N, Plaul K, et al. Laparoscopic para-aortic and pelvic lymphadenectomy: experience with 150 patients and review of the literature. Gynecol Oncol. 1998;71:19-28.
25. Schlaerth JB, Spirtos NM, Carson LF, et al. Laparoscopic retroperitoneal lymphadenectomy followed by immediate laparotomy in women with cervical cancer: a Gynecologic Oncology Group study. Gynecol Oncol. 2002;85:81-88.
26. Cox CE, Dupont E, Whitehead GF, et al. Age and body mass index may increase the chance of failure in sentinel lymph node biopsy for women with breast cancer. Breast J. 2002;8:88-91.
27. Shen SS, Haupt BX, Ro JY, et al. Number of lymph nodes examined and associated clinicopathologic factors in colorectal carcinoma. Arch Pathol Lab Med. 2009;133:781-786.
28. Neuman H, Carey LA, Ollila DW, et al. Axillary lymph node count is lower after neoadjuvant chemotherapy. Am J Surg. 2006;191:827-829.
29. Rullier A, Laurent C, Capdepont M, et al. Lymph nodes after preoperative chemoradiotherapy for rectal carcinoma: number, status, and impact on survival. Am J Surg Pathol. 2008;32:45-50.
30. Di Girolamo V, Laguens RP, Coronato S, et al. Quantitative and functional study of breast cancer axillary lymph nodes and those draining other human malignant tumors. J Exp Clin Cancer Res. 2000;19:155-159. (Pubitemid 30490153)
31. Eremin O, Roberts P, Plumb D, et al. Human regional tumour lymph nodes: alterations of micro-architecture and lymphocyte subpopulations. Br J Cancer. 1980;41:62-72. (Pubitemid 10215418)
32. Laguens G, Coronato S, Laguens R, et al. Human regional lymph nodes draining cancer exhibit a profound dendritic cell depletion as comparing to those from patients without malignancies. Immunol Lett. 2002;84:159-162.